Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00389311 · ClinicalTrials.gov registry record · Early Phase 1
A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides
A Early Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
NCT00389311: Completed Early Phase 1 study, sponsored by Johns Hopkins University.
NCT00389311 is a Early Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00389311, a Early Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if detectable changes in permeability of the lining of the colon are caused by either application of HIV microbicide gels or medical procedures, such as flexible sigmoidoscopy.
Interventions
- DRUG Nonoxynol-9
- DRUG Normosol-R
- PROCEDURE Gastrointestinal instrumentation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00389311
The ClinicalTrials.gov registry entry for NCT00389311 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nonoxynol-9 is the first listed.
NCT00389311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00389311 about?
NCT00389311 is a clinical study titled "A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides". The purpose of this study is to determine if detectable changes in permeability of the lining of the colon are caused by either application of HIV microbicide gels or medical procedures, such as flexible sigmoidoscopy.
What is the current status of trial NCT00389311?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2007-04. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00389311?
The interventions under investigation include: Nonoxynol-9 (DRUG), Normosol-R (DRUG), Gastrointestinal instrumentation (PROCEDURE).
Who is sponsoring clinical trial NCT00389311?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.